Epidemiology of peripheral artery disease.

By M. Criqui, V. Aboyans. Circulation Research, 2015

1,541 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Global vascular guidelines on the management of chronic limb-threatening ischemia (2019, background): “Strategies are urgently required to improve availability and affordability of drugs so that vascular specialists can treat their patients to target.321 There have been concerns that drugs reducing heart rate and blood pressure will worsen ischemia in patients with PAD.”
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (2016, background): “N/A Diabetes mellitus is an important risk factor for the development of PAD (187).”
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. (2016, result): “find higher rates in men than women, but this difference is less apparent in studies using ankle-brachial SBP index.(40) Overview of Modifiable Causes of Atherosclerosis”
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk) (2017, result): “%] in PAD; 1.4% [95% CI, 0.7%–2.1”